Evertz Technologies Limited announced fiscal 2026 results with record annual revenue of $515.8 million, up from $501.6 million the prior year, and net earnings of $64.4 million, a $4.7 million increase. Growth was driven by an 8% rise in recurring software and services revenue to $240.7 million and a 16% increase in international revenue to $148 million. Quarterly revenue also rose 3% to $131.6 million with net earnings up 17% to $15.2 million. The company declared a quarterly dividend of $0.205 per share and maintains a strong backlog exceeding $237 million, signaling continued demand and growth potential.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
